Buchumschlag

A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Döhner, Hartmut (Verfasst von) , Müller-Tidow, Carsten (Verfasst von) , Lübbert, Michael (Verfasst von) , Fiedler, Walter (Verfasst von) , Krämer, Alwin (Verfasst von) , Westermann, Jörg (Verfasst von) , Bug, Gesine (Verfasst von) , Schlenk, Richard Friedrich (Verfasst von) , Krug, Utz (Verfasst von) , Goeldner, Rainer-Georg (Verfasst von) , Hilbert, James (Verfasst von) , Taube, Tillmann (Verfasst von) , Ottmann, Oliver G. (Verfasst von)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: May 2019
In: British journal of haematology
Year: 2019, Jahrgang: 185, Heft: 3, Pages: 583-587
ISSN:1365-2141
DOI:10.1111/bjh.15563
Online-Zugang:Verlag, Volltext: https://doi.org/10.1111/bjh.15563
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15563
Volltext
Verfasserangaben:Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann

MARC

LEADER 00000caa a2200000 c 4500
001 1662827520
003 DE-627
005 20240930114000.0
007 cr uuu---uuuuu
008 190404s2019 xx |||||o 00| ||eng c
024 7 |a 10.1111/bjh.15563  |2 doi 
035 |a (DE-627)1662827520 
035 |a (DE-599)KXP1662827520 
035 |a (OCoLC)1341206624 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Döhner, Hartmut  |d 1957-  |e VerfasserIn  |0 (DE-588)110666585  |0 (DE-627)729880842  |0 (DE-576)375358846  |4 aut 
245 1 2 |a A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia  |c Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann 
264 1 |c May 2019 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 19 November 2018 
500 |a Gesehen am 04.04.2019 
650 4 |a acute myeloid leukaemia 
650 4 |a Aurora B kinase 
650 4 |a BI 811283 
650 4 |a low-dose cytarabine 
650 4 |a phase I 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Lübbert, Michael  |e VerfasserIn  |4 aut 
700 1 |a Fiedler, Walter  |e VerfasserIn  |4 aut 
700 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
700 1 |a Westermann, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Bug, Gesine  |e VerfasserIn  |4 aut 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
700 1 |a Krug, Utz  |e VerfasserIn  |4 aut 
700 1 |a Goeldner, Rainer-Georg  |e VerfasserIn  |4 aut 
700 1 |a Hilbert, James  |e VerfasserIn  |4 aut 
700 1 |a Taube, Tillmann  |e VerfasserIn  |4 aut 
700 1 |a Ottmann, Oliver G.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t British journal of haematology  |d Oxford [u.a.] : Wiley-Blackwell, 1955  |g 185(2019), 3, Seite 583-587  |h Online-Ressource  |w (DE-627)269758941  |w (DE-600)1475751-5  |w (DE-576)09113997X  |x 1365-2141  |7 nnas  |a A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia 
773 1 8 |g volume:185  |g year:2019  |g number:3  |g pages:583-587  |g extent:5  |a A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia 
856 4 0 |u https://doi.org/10.1111/bjh.15563  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15563  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190404 
993 |a Editorial 
994 |a 2018 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 910000  |d 910100  |e 910000PS129025380  |e 910100PS129025380  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1662827520  |e 3418114431 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia","title":"A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia"}],"person":[{"given":"Hartmut","display":"Döhner, Hartmut","role":"aut","family":"Döhner"},{"display":"Müller-Tidow, Carsten","role":"aut","family":"Müller-Tidow","given":"Carsten"},{"given":"Michael","display":"Lübbert, Michael","role":"aut","family":"Lübbert"},{"display":"Fiedler, Walter","role":"aut","family":"Fiedler","given":"Walter"},{"given":"Alwin","display":"Krämer, Alwin","role":"aut","family":"Krämer"},{"family":"Westermann","role":"aut","display":"Westermann, Jörg","given":"Jörg"},{"family":"Bug","display":"Bug, Gesine","role":"aut","given":"Gesine"},{"given":"Richard Friedrich","family":"Schlenk","display":"Schlenk, Richard Friedrich","role":"aut"},{"display":"Krug, Utz","role":"aut","family":"Krug","given":"Utz"},{"family":"Goeldner","display":"Goeldner, Rainer-Georg","role":"aut","given":"Rainer-Georg"},{"family":"Hilbert","role":"aut","display":"Hilbert, James","given":"James"},{"given":"Tillmann","family":"Taube","display":"Taube, Tillmann","role":"aut"},{"display":"Ottmann, Oliver G.","role":"aut","family":"Ottmann","given":"Oliver G."}],"note":["Veröffentlicht: 19 November 2018","Gesehen am 04.04.2019"],"language":["eng"],"relHost":[{"recId":"269758941","id":{"doi":["10.1111/(ISSN)1365-2141"],"zdb":["1475751-5"],"issn":["1365-2141"],"eki":["269758941"]},"origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedKey":"1955","dateIssuedDisp":"1955-"}],"disp":"A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemiaBritish journal of haematology","pubHistory":["1.1955 -"],"corporate":[{"role":"isb","display":"British Society for Haematology"},{"display":"European Hematology Association","role":"isb"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"part":{"text":"185(2019), 3, Seite 583-587","year":"2019","issue":"3","extent":"5","volume":"185","pages":"583-587"},"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"language":["eng"],"note":["Gesehen am 08.05.08"],"title":[{"title_sort":"British journal of haematology","title":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology"}]}],"name":{"displayForm":["Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann"]},"physDesc":[{"extent":"5 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"May 2019","dateIssuedKey":"2019"}],"id":{"doi":["10.1111/bjh.15563"],"eki":["1662827520"]},"recId":"1662827520"} 
SRT |a DOEHNERHARPHASEITRIA2019 

Ähnliche Einträge